Palisade Bio PALI
NASDAQ PALI
$1.39 +0.04 (+2.96%)
As of: Oct 1, 2026 · 12:05 PM EDT

Palisade Bio (PALI) Other Non-Current Liabilities (2012 - 2026)

Updated

Palisade Bio (PALI) posted Other Non-Current Liabilities of $259,000 for Q2 2026, up 245.3% from $75,000 a year earlier but down 4.4% from the prior quarter.

Analysis

Palisade Bio (PALI) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, Palisade Bio's Other Non-Current Liabilities came in at $266,000, up 77.3% from FY2024.

  • Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
  • In prior years, Palisade Bio's Other Non-Current Liabilities was $150,000 in FY2024 (+145.9%), $61,000 in FY2023 (unchanged), $61,000 in FY2022 (-97.7%) and $2.65 million in FY2021 (+44.9%).
  • Quarterly Other Non-Current Liabilities has run from a low of $2,000 in Q2 2023 to a high of $9.43 million in Q3 2021 over five years.
  • On a year-over-year basis, Other Non-Current Liabilities has increased in each of the last seven quarters, with growth averaging 151.7% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q1 2022, with growth of 889.5%; the weakest was Q2 2023, with a decline of 99.6%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $271,000 (Q1 2026), $266,000 (Q4 2025) and $283,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Palisade Bio 234.35 Mn -162.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 259,000.00
Mar 31, 2026 271,000.00
Dec 31, 2025 266,000.00
Sep 30, 2025 283,000.00
Jun 30, 2025 75,000.00
Mar 31, 2025 80,000.00
Dec 31, 2024 150,000.00
Sep 30, 2024 45,000.00
Jun 30, 2024 60,000.00
Mar 31, 2024 61,000.00
Dec 31, 2023 61,000.00
Sep 30, 2023 212,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 18,000.00
Dec 31, 2022 61,000.00
Sep 30, 2022 84,000.00
Jun 30, 2022 469,000.00
Mar 31, 2022 1.69 Mn
Dec 31, 2021 2.65 Mn
Sep 30, 2021 9.43 Mn
API Access

Palisade Bio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PALI&period=max&api_key=YOUR_API_KEY